Centre de NeuroImagerie de Recherche

Centre de NeuroImagerie de Recherche
Name	Centre de NeuroImagerie de Recherche
Native name	Centre de NeuroImagerie de Recherche
Established	2000s
Location	Lyon, France
Type	Neuroimaging research center
Affiliations	Université Claude Bernard Lyon 1, CNRS, Inserm, Hospices Civils de Lyon

Centre de NeuroImagerie de Recherche

The Centre de NeuroImagerie de Recherche is a multidisciplinary neuroimaging research center in Lyon associated with major French and international institutions. The center integrates expertise from university hospitals and national research organizations to pursue human brain mapping, neurodegenerative disease biomarkers, and translational neuropsychiatry. Its programs connect basic neuroscience, clinical neurology, and cognitive science through advanced imaging, computational modeling, and large cohort studies.

History

The center grew from collaborations among Université Claude Bernard Lyon 1, CNRS, Inserm, and the Hospices Civils de Lyon during the early 21st century, reflecting trends established by institutions such as Massachusetts General Hospital, Karolinska Institutet, University College London, University of Oxford, and Stanford University. Its founding phase involved partnerships with regional actors like Hospices Civils de Marseille and national programs inspired by initiatives at Institut du Cerveau et de la Moelle épinière and international consortia such as Human Connectome Project and ENIGMA consortium. Subsequent expansions echoed technological deployments seen at Max Planck Institute for Human Cognitive and Brain Sciences, École Normale Supérieure, and McGill University. Over time the center hosted visiting scholars from Johns Hopkins University, Harvard Medical School, Karolinska University Hospital, and University of California, San Francisco and contributed to networks that include European Research Council-funded teams and projects aligned with Horizon 2020.

Mission and Research Focus

The center’s mission emphasizes translational neuroimaging research bridging basic and clinical domains, modeled on missions at Institut Pasteur, Mayo Clinic, Salk Institute, and Bell Labs-era interdisciplinary labs. Research priorities target neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and Huntington's disease; psychiatric conditions including schizophrenia, major depressive disorder, and bipolar disorder; and developmental concerns such as autism spectrum disorder and attention deficit hyperactivity disorder. Studies integrate approaches developed at centers like Paul Scherrer Institute, Riken Center for Brain Science, Donders Institute, and Cold Spring Harbor Laboratory to advance biomarkers, connectomics, and neuromodulation. The center aligns with clinical trial frameworks used by European Medicines Agency and collaborates with registries similar to Alzheimer's Disease Neuroimaging Initiative and cohorts patterned after UK Biobank.

Facilities and Imaging Modalities

Facilities include high-field MRI suites, positron emission tomography systems, and combined PET/MRI platforms comparable to installations at NeuroSpin, University of Cambridge, Yale University, and University of Toronto. Equipment lists reflect technology adopted at Siemens Healthineers-equipped centers, including ultra-high-field 7T MRI, 3T MRI, and diffusion-weighted imaging pipelines similar to those employed at Princeton University and EPFL. The center operates radiochemistry labs for tracers used in studies modeled on protocols from Weizmann Institute of Science and Brookhaven National Laboratory, and maintains electrophysiology and magnetoencephalography suites inspired by setups at University of Glasgow and University of Helsinki. Computational infrastructure supports analyses using methods from MIT CSAIL, ETH Zurich, University of California, Berkeley, and Carnegie Mellon University.

Research Programs and Projects

Major research programs encompass longitudinal cohort studies, multimodal biomarker discovery, and interventional trials mirroring efforts at European Alzheimer’s Disease Consortium, BRAIN Initiative, and NIH. Projects include connectome mapping efforts akin to Human Connectome Project, PET ligand development paralleling work at Mayo Clinic and Vanderbilt University, and machine learning pipelines inspired by studies at Google DeepMind and OpenAI collaborators. Clinical trials involve pharmacological studies following regulatory paths similar to those at ANSM and device trials comparable to those overseen by Food and Drug Administration. Collaborative longitudinal cohorts echo designs from Framingham Heart Study and Rotterdam Study adapted for neurodegeneration and cognitive aging.

Collaborations and Partnerships

The center maintains academic collaborations with Université Claude Bernard Lyon 1, ENS de Lyon, Institut NeuroMyoGène, Centre Léon Bérard, and national agencies such as Inserm and CNRS, and engages international partners like University of Oxford, University College London, Harvard Medical School, Karolinska Institutet, and McGill University. Industrial partnerships involve medical imaging companies including Siemens Healthineers, GE Healthcare, and Philips as well as biotech firms and startups incubated alongside Ecole Centrale de Lyon and regional innovation clusters. Consortium roles include participation in European projects funded by European Commission programs and collaborative networks like ENIGMA consortium and Human Brain Project.

Education, Training, and Outreach

The center provides graduate training and postdoctoral mentorship linked to Université Claude Bernard Lyon 1, doctoral schools like those at Sorbonne Université, and international exchange programs with Massachusetts Institute of Technology, Columbia University, and ETH Zurich. Educational offerings include workshops on imaging analysis reflective of curricula from FMRIB Centre and summer schools modeled on Neuroinformatics Summer School traditions. Public outreach is coordinated with hospitals such as Hospices Civils de Lyon and cultural partners like Musée des Confluences to communicate findings to broader audiences and patient advocacy groups including Alzheimer Europe and European Parkinson's Disease Association.

Governance and Funding

Governance is shared among university, hospital, and national research stakeholders similar to structures at Institut Pasteur and Collège de France, with advisory boards featuring academics from University of Cambridge, Yale School of Medicine, and University of California, Los Angeles. Funding sources combine grants from agencies such as ANR, European Research Council, philanthropic contributions patterned after Wellcome Trust, and industry research contracts comparable to partnerships at Roche and GlaxoSmithKline.

Category:Neuroscience research institutes